NIFTY  9,360.55  -0.27%
  SENSEX  30,301.60  -0.21%
 CURRENCY  Rs  64.89/$ 72.59/€, 84.18/£
  GOLD  28,688.00  -0.43%
  SILVER  39,762.00  -0.49%
  DAX  12,659.20  0.31%
  FTSE  7,485.29  -0.15%
  CAC  5,348.16  0.41%
  HANG SENG  25,428.50  0.10%
  NIKKEI  19,743.00  0.66%
  Shanghai Composite  3,064.08  0.03%
  DOW JONES  20,937.90  0.21%
  NASDAQ  6,138.71  0.08%
  S&P 500  2,398.42  0.18%
SOURCES TO COGENCIES : Cabinet Approves Proposal For Abolition Of Foreign Investment Promotion Board SOURCES TO COGENCIES : Cabinet Approves Proposal On 2017-18 Sugarcane Prices SOURCES TO COGENCIES : Need For Cabinet Nod For FDI Over Rs 5000 Cr To Remain TATA INVEST Q4 EARNINGS : PAT Rs 16.1 Cr Vs Rs 22.3 Cr YoY TATA INVEST Q4 EARNINGS : Revenue Rs 35.8 Cr Vs Rs 32.3 Cr YoY TATA INVEST Q4 EARNINGS : To Pay Dividend Of Rs 18/Share PRASUN GAJRI HDFC LIFE : I.T. Stocks May Perform Better On A Short-Term Basis FROM REUTERS : KOC & Tata Group Sign Joint Venture To Tap Into White Goods Consumer Market

Piramal: Focus On Domestic Mkt

Video:

Play this video

December 30: Watch as Piramal Enterprises’ Ajay Piramal discusses the group’s entry into pharmaceuticals with the acquisition of Nicholas in 1988. He tells Mini Menon that in the Indian market a well-established brand makes a big difference.